Business
Media
Conferences
Publications
CME/CE
Resources
Subscribe

Christopher Lee, MD

Articles by Christopher Lee, MD

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer

ByChristopher Lee, MD

October 2nd 2025

Latest Updated Articles

Genomic testing helps inform treatment intensity decisions in intermediate-risk prostate cancer
October 2nd 2025

Trending on Urology Times

FDA approves Titan Prime Inflatable Penile Prosthesis

FDA approves cefepime and zidebactam for complicated UTI

Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617

Enzalutamide associated with greater cognitive decline than darolutamide in advanced prostate cancer

PROTEUS: Apalutamide plus ADT before and after RP cuts metastasis risk